Who is the manufacturer of Volumat Line?

Fresenius Kabi filed the 510(k) submission for Volumat Line (K220301).

What is the FDA product code for Volumat Line?

FPA. It is classified under 21 CFR 880.5440 as a Class 2 device in the General Hospital panel.

What is the regulatory pathway for Volumat Line?

510(k) clearance (submission type: Traditional).

What are the predicate devices for Volumat Line?

Intravascular Administration Sets (K203609).

Who can help prepare an FDA 510(k) submission like Volumat Line?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

Volumat Line

K220301 · Fresenius Kabi · FPA · Jun 2, 2023 · General Hospital

Device Facts

Record ID	K220301
Device Name	Volumat Line
Applicant	Fresenius Kabi
Product Code	FPA · General Hospital
Decision Date	Jun 2, 2023
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 880.5440
Device Class	Class 2
Attributes	Therapeutic, Pediatric

Intended Use

The Volumat™ Line is intended for the administration of drugs, solutions and blood products.

Device Story

Volumat™ Line consists of various IV administration and transfusion sets; components include spike, drip chamber, roller clamp, pump segment, downstream filter, needle-free port, and burette. Sets deliver parenteral fluids, medications, or blood products from containers to patient vascular systems. Operation occurs via gravity or integration with Agilia VP MC/Volumat MC Agilia infusion pumps. Device used in clinical settings by healthcare providers. Output is controlled fluid/blood delivery; clinical decision-making relies on provider-set infusion parameters. Benefits include precise, reliable delivery of therapeutic substances.

Clinical Evidence

No clinical data. Substantial equivalence demonstrated via bench testing, including flow rate accuracy, leakage, tensile strength, microbial ingress, particulate testing, and biocompatibility evaluation.

Technological Characteristics

Materials: Polystyrene, PVC, Polyurethane, Polypropylene, ABS, Copolyester, Polyethersulfone, Stainless steel. Principle: Gravity or pump-driven infusion. Connectivity: Mechanical interface with Agilia pumps. Sterilization: Ethylene oxide (ISO 11135:2020, SAL 10^-6). Standards: ISO 8536-4, 8536-8, 8536-14, ISO 80369-20, ISO 10993, USP <788>.

Indications for Use

Indicated for adult patients (and pediatric patients for specific models) for the infusion of parenteral fluids, medications, or blood derivatives from a container into the patient's vascular system via a vascular access device, using Agilia VP MC/Volumat MC Agilia pumps or gravity flow.

Regulatory Classification

Identification

An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.

Special Controls

*Classification.* Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.

Predicate Devices

Intravascular Administration Sets (K203609)

Reference Devices

Volumat MC Agilia Infusion Pump (K121613)
Agilia VP MC Pump (K210073)

Related Devices

K221121 — Volumat Polyethylene I.V. Administration Set · Fresenius Kabi · Jun 16, 2023
K192375 — Intellifuse Administration and Intellifuse Blood Administration Sets · Smiths Medical Asd, Inc. · Sep 18, 2020
K170595 — IV Administration Sets · B.Braun Medical, Inc. · Nov 7, 2017
K162601 — Infusion Set for Single Use · Shinva Ande Healthcare Apparatus Co., Ltd. · May 31, 2017
K050906 — VITALCARE I.V. ADMINISTRATION SET · Vitalcare Group, Inc. · Aug 23, 2005

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text. June 2, 2023 Fresenius Kabi % Keith Dunn Director Regulatory Affairs Fresenius Kabi LLC, USA 3 Corporate Dr Suite 300 Lake Zurich, Illinois 60047 Re: K220301 Trade/Device Name: Volumat™ Line Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: Class II Product Code: FPA Dated: May 3, 2023 Received: May 3, 2023 Dear Keith Dunn: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's {1}------------------------------------------------ requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Porsche Bennett For Dr. David Wolloscheck, Ph.D. Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices. and Human Factors OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## Indications for Use 510(k) Number (if known) K220301 Device Name Volumat™ Line Indications for Use (Describe) IV Administration Set for the infusion of parenteral fluids and medications from a container into the patient's vascular system through a vascular access device with Agilia VP MC/Volumat MC Agilia pump or gravity only. Transfusion Set for the infusion of blood derivatives from a container into the patient's vascular system through a vascular access device with Agilia VP MC/Volumat MC Agilia pump or gravity only. Type of Use (Select one or both, as applicable) | <input checked="" type="checkbox"/> Prescription Use (Part 21 CFR 801 Subpart D) | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | <input type="checkbox"/> Over-The-Counter Use (21 CFR 801 Subpart C) | #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of three blue wavy lines on the left and the words "FRESENIUS KABI" in blue on the right. The word "FRESENIUS" is on top of the word "KABI". Fresenius Kabi Three Corporate Drive Lake Zurich, Illinois 60047 T 847-550-2300 T 847-550-2300 T 888-391-6300 www.fresenius-kabi.us ## 510(k) SUMMARY- K220301 | 1. Date Prepared: | June 2, 2023 | |-------------------|--------------| |-------------------|--------------| 2. Submitter Information | Name: | Fresenius Kabi | |---------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Address: | Fresenius Kabi AG 61346 Bad Homburg Germany | | Contact Person: | Keith Dunn Director, Regulatory Affairs Fresenius Kabi USA, LLC Three Corporate Drive, Lake Zurich, IL 60047 USA Phone: (224) 817-2430 Fax: (847) 550 2960 E-mail: keith.dunn@fresenius-kabi.com | | Secondary Contact Person: | Jason Ma Sr. Manager, Regulatory Affairs Fresenius Kabi USA, LLC Three Corporate Drive, Lake Zurich, IL 60047 USA Phone: (224) 817-4100 Fax: (847) 550 2960 E-mail: Jason.ma01@fresenius-kabi.com | # 3. Device Name and Classification | Device Trade Name: | Volumat™ Line | |----------------------|-----------------------------------| | Common Name: | I.V. Administration Set | | Classification Name: | Intravascular administration set | | Regulation Number: | 21 CFR 880.5440 | | Regulatory Class: | Class II | | Product Code: | FPA | | 4. Predicate Device | | | Device Trade Name: | Intravascular Administration Sets | {4}------------------------------------------------ Image /page/4/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of three blue, wavy lines on the left side. To the right of the lines, the words "FRESENIUS" and "KABI" are written in blue, with "FRESENIUS" on top of "KABI". Fresenius Kabi Three Corporate Drive ake Zurich, Illinois 60047 847-550-2300 1 888-391-6300 www.fresenius-kabi.us Common Name: Classification Name: Regulatory Class: Product Code: 510(k) Number: Intravascular Administration Set 21 CFR 880.5440 Class II FPA K203609 ### 5. Device Description The Volumat 100 Line is available for dedicated use with the Volumat MC Agilia Infusion Pump and the Agilia VP MC Pump, or they can administer parenteral fluids and medications by gravity flow. Both the Volumat MC Agilia Infusion Pump and the Volumat I.V. Administration Sets were cleared under K121613, and the Agilia VP MC Pump was cleared under K210073. The Volumat TM Line components include a spike, drip chamber, roller clamp, upstream/downstream clamp, backcheck valve, pump segment, upstream filter, needle free port, rotating male luer lock, luer lock connector, Yconnector, tubing, and burette. | Set Number | Description | |------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | M46441960 | Volumat Line IV Administration Set with spike, air vent, drip chamber, roller clamp, pump segment, downstream clamp, needle-free port, and rotating male luer | | M46441985 | Volumat Line IV Administration Set with non-siliconized spike, air vent, drip chamber, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer | | M46442460 | Volumat Line IV Administration Set with spike, air vent, drip chamber, roller clamp, pump segment, 1.2micron filter (neutrally charged), downstream clamp, downstream needle-free port, rotating male luer | | M46443160 | Volumat Line Transfusion Set with spike, roller clamp, drip chamber with 200micron filter, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer | | M46443450 | Volumat Line IV Administration Set with spike, air vent, drip chamber, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer | | M46444160 | Volumat Line IV Administration Set with spike, air vent, drip chamber, roller clamp, pump segment, 0.2micron filter downstream clamp, downstream needle-free port, rotating male luer | | M46444175 | Volumat Line IV Administration Set with non-siliconized spike, air vent, drip chamber, roller clamp, pump segment, 0.2micron filter, downstream clamp, downstream needle-free port, rotating male luer, | | M46445260 | Volumat Line IV Administration Set with spike, air vent spike, upstream clamp, (5) air vent burette, 150 mL burette with 15 $ \mu $ m filter and upstream needle-free port, drip chamber, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer | | M46445270 | Volumat Line IV Administration Set with spike, air vent spike, upstream clamp, air vent | {5}------------------------------------------------ Image /page/5/Picture/0 description: The image contains the logo for Fresenius Kabi. The logo consists of three blue, curved lines on the left side, followed by the text "FRESENIUS" in bold, blue letters on the right. Below "FRESENIUS" is the word "KABI", also in bold, blue letters. resenius K ree Cornorate Drive 888-391-6300 www.fresenius-kabi.us | Set Number | Description | |------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | burette, 150 mL burette with 15µm filter and upstream needle-free port, drip chamber, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer | | M46445475 | Volumat Line IV Administration Set with non-siliconized spike, air vent, drip chamber, upstream clamp, backcheck valve, upstream, needle-free port, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer | | M46445660 | Volumat Line IV Administration Set with spike, air vent, drip chamber, upstream clamp, backcheck valve, upstream needle-free port, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer | | M46445670 | Volumat Line IV Administration Set with spike, air vent, drip chamber, upstream clamp, backcheck valve, 2 upstream needle-free ports, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer | | M46445690 | Volumat Line IV Administration Sets with spike, air vent, drip chamber, upstream clamp, backcheck valve, upstream needle-free ports, roller clamp, pump segment, downstream clamp, 2 downstream needle-free ports, rotating male luer | | M46445780 | Volumat Line IV Administration Set with spike, air vent, drip chamber, upstream clamp, backcheck valve, upstream needle-free port, roller clamp, pump segment, downstream clamp, 2 downstream needle-free ports, rotating male luer | | M46445860 | Volumat Line IV Administration Set with spike, air vent, drip chamber, upstream clamp, backcheck valve, upstream needle-free port, roller clamp, pump segment, 0.2micron filter, downstream clamp, downstream needle-free port, rotating male luer | # 6. Principle of Operation The range of sets provides options for intermittent or continuous delivery of parenteral fluids (solutions, colloids, parenteral nutrition) and medications (including but not limited to diluted drugs, chemotherapy) through clinically accepted intravenous (I.V.) routes of administration and transfusions of blood and blood derivative products. The device may be used for adult patients. The devices M46445260 and M46445270 may be used for pediatric patients. # 7. Indication for Use/ Intended Use ### Indication for Use: I.V. Administration Set for the infusion of parenteral fluids and medications from a container into the patient's vascular system through a vascular access device with Agilia VP MC/Volumat MC Agilia pump or gravity only. Transfusion set for the infusion of blood and blood derivatives from a container into the patient's vascular system through a vascular access device with Agilia VP MC/Volumat MC Agilia pump or gravity only. {6}------------------------------------------------ Image /page/6/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of three blue wavy lines on the left and the words "FRESENIUS KABI" in blue on the right. The word "FRESENIUS" is on top of the word "KABI". v.fresenius-kabi.us ### Intended Use: The Volumat TM Line is intended for the administration of drugs, solutions and blood products. ## 8. Comparison of the Technological Characteristics with the Predicate Device The technological characteristics of the subject device are substantially equivalent to those of the predicate device in regard to the following technological characteristics: - Principle of operation and conditions of use of the subject device are the same as ● those of the predicate device. - . Materials of the proposed device do not raise new questions of safety and effectiveness, as demonstrated by performance testing and biocompatibility evaluation. - . Physical specifications of the subject device are equivalent to those of the predicate device. Both devices have a needle free access port. The subject device incorporates a neutral displacement needleless access port with the same intended use A comparison between the predicate device and the subject device is provided in Table 1 and Table 2. | Technological Characteristics | Volumat TM Line (Subject Device) | Baxter Administration Set K203609 (Predicate Device) | Assessment of Differences | |----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Indication for Use | I.V. Administration Set for the infusion of parenteral fluids and medications from a container into the patient's vascular system through a vascular access device with Agilia VP MC/Volumat MC Agilia pump or gravity only. Transfusion set for the infusion of blood and blood derivatives from a container into the patient's vascular system through a | For the administration of fluids from a container into the patients' vascular system through a vascular access device. | Similar. Both I.V. administration sets are used to administer fluids from a container to a patient. However, the Subject Device interoperates with infusion systems that have been cleared in other 510(k) submissions including K121613 and K210073. | | Technological Characteristics | Volumat ™ Line (Subject Device) | Baxter Administration Set K203609 (Predicate Device) | Assessment of Differences | | | vascular access device with Agilia VP MC/Volumat MC Agilia pump or gravity only. | | | | Operating Mechanism | The Volumat administration sets deliver the intravenous infusions via an infusion pump through a pumping mechanism ("cassette") or by gravity flow. | The Baxter administration sets can be used to deliver solutions for gravity or pump by infusion of I.V. fluids. | Similar, both devices can be used with an infusion pump or by gravity flow. The predicate device does not have a pumping mechanism ("cassette"). Difference has been verified through performance testing including flow rate accuracy under various environmental conditions (temperature, pressure, humidity) which demonstrate equivalence. | | Sterile | Yes | Yes | Same | | Non-Pyrogenic | Yes | Yes | Same | | Single Use | Yes | Yes | Same | | Length | 75-115 inches | 69-133.5 inches | Similar. The sets included in the subject device range in length from 75 inches to 115 inches which is within the range of the predicate device. Difference tested according to ISO 8536-4 and flow rate accuracy to demonstrate the subject device performance. | | Priming Volume | 20-29 mL | 6.1 to 21.2 mL | Similar. The Volumat set requires more priming volume than the predicate. Bench testing confirmed that the differences in priming volume do not impact safety or effectiveness. Difference tested to ISO 8536-4 to demonstrate equivalence. | | Internal Tube Diameter | 0.098 to 118 inches | 0.102 to 133 inches | | | Technological Characteristics | Volumat ™ Line (Subject Device) | Baxter Administration Set K203609 (Predicate Device) | Assessment of Differences | | External Tube Diameter | 1.61 inches | 1.42 to 2.09 inches | Similar internal and external diameter and approximate range of the predicate device. Difference tested to ISO 8536-8 has demonstrated equivalence. | | Components | | | | | Spike | Yes | Yes | Different. The subject device includes an additional pumping segment, downstream filter, and burette, however, no significant difference between the subject and predicate administration sets that would raise new issues of safety or efficacy. | | Drip chamber | Yes | Yes | | | Backcheck Valve | Yes | Yes | | | Pump Segment | Yes | No | | | Downstream Filter | Yes | No | | | Needle Free Port | Yes | Yes | | | Male Luer | Yes | Yes | | | Roller Clamp | Yes | Yes | | | Connector Luer Lock | Yes | Yes | | | Burette | Yes | No | The differences have been verified in various aspects to demonstrate the subject device's safety and performance including: Biocompatibility testing according to ISO 10993 collateral standards, Microbial Ingress Testing, and Particulate Testing; Performance Testing according to ISO 8536-4, ISO 80369-20, ISO 8536-8 and ISO 8436-14. | ### Table 1: Summary of Substantial Equivalence Comparison—Primary Sets {7}------------------------------------------------ Image /page/7/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of three blue wavy lines on the left and the words "FRESENIUS KABI" in blue on the right. The word "FRESENIUS" is on top of the word "KABI". **Fresenius Kabi** Fresemius Kabi Thresemius Italia Drive Lake Zurion atabile Drive Lake Zurion 223000 T 888-3991-233000 www.fresenius-kabil.us {8}------------------------------------------------ Image /page/8/Picture/0 description: The image contains the logo for Fresenius Kabi. On the left side of the logo are three blue vertical wavy lines. To the right of the wavy lines is the text "FRESENIUS" in blue, with the text "KABI" in blue below it. Fresenius Kabi Three Corporate Drive Lake Zurich, Illinois 60047 T 847-550-2300 T 847-550-2300 T 888-391-6300 www.fresenius-kabi.us ### Table 2: Summary of Substantial Equivalence Comparison—Transfusion Sets | Technological Characteristics | Modified Volumat I.V. Administration Set (Subject Device) | Baxter Administration Set K203609 (Predicate Device) | Assessment of Differences | |----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Indication for Use | Transfusion set for infusion pumps (Agilia VP MC pumps/Volumat | For the administration of fluids from a | Similar. Slight difference but both the subject device | | Technological Characteristics | Modified Volumat I.V. Administration Set (Subject Device) | Baxter Administration Set K203609 (Predicate Device) | Assessment of Differences | | | MC Agilia pump or gravity only.) | container into the patients' vascular system through a vascular access device. | and predicate device include a blood transfusion set. However, the Subject Device interoperates with infusion systems that have been cleared in other 510(k) submissions including K121613 and K210073. | | Operating Mechanism | The Volumat administration sets deliver the transfusion via an infusion pump through a pumping mechanism ("cassette") or by gravity flow. | The Baxter administration sets can be used to deliver solutions for gravity or pump by infusion of I.V. fluids. | Similar, both devices can be used with an infusion pump or by gravity flow. The predicate device does not have a pumping mechanism ("cassette"). Difference has been verified through performance testing including flow rate accuracy under various environmental conditions (temperature, pressure, humidity) which demonstrate equivalence. | | Sterile | Yes | Yes | Same | | Non-Pyrogenic | Yes | Yes | Same | | Single Use | Yes | Yes | Same | | Length | 110 inches | 79 inches | Similar. The transfusion set included in the subject device is longer than the predicate device. Testing did not raise any new issues of safety or efficacy. Difference tested according to ISO 8536-4 and flow rate accuracy to demonstrate the subject device performance. | | Priming Volume | 33 ml | 6.1 to 21.2 mL | Similar. The Volumat set requires more priming volume than the predicate. Bench testing confirmed that the differences in priming volume does not impact safety or effectiveness. | | Technological Characteristics | Modified Volumat I.V. Administration Set (Subject Device) | Baxter Administration Set K203609 (Predicate Device) | Assessment of Differences | | | | | Difference tested to ISO 8536-4 to demonstrate equivalence. | | Internal Tube Diameter | 0.118 inches | 0.102 to 0.133 inches | Similar internal diameter and approximate range of the | | External Tube Diameter | 1.61 inches | 1.42 to 2.09 inches | predicate device. | | | | | Difference tested to ISO 8536-8 has demonstrated equivalence. | | | | Components | | | Spike | Yes | Yes | Different. The subject device | | Drip chamber | Yes | Yes | includes a pump segment, | | Pump Segment | Yes | No | however, no significant | | Needle Free Port | Yes | Yes | difference between the | | Male Luer | Yes | Yes | administration sets that | | Y-Connector | Yes | Yes | would raise new issues of safety or efficacy. | | | | | The differences have been verified in various aspects to demonstrate the subject device's safety and performance including: Biocompatibility testing according to ISO 10993 collateral standards, Microbial Ingress Testing, and Particulate Testing: Performance Testing according to ISO 8536-4, ISO 80369-20, ISO 8536-8 and ISO 8436-14. | {9}------------------------------------------------ Image /page/9/Picture/0 description: The image shows the logo for Fresenius Kabi. The logo consists of a blue abstract symbol on the left, resembling three wavy lines. To the right of the symbol, the words "FRESENIUS" and "KABI" are written in blue, with "FRESENIUS" on top of "KABI". The logo is simple and modern, with a focus on the company name. **Fresenius Kabi** Fresemius Kabi Thresemius Italia Drive Lake Zurion atabile Drive Lake Zurion 223000 T 888-3991-233000 www.fresenius-kabil.us {10}------------------------------------------------ Image /page/10/Picture/0 description: The image shows the logo for Fresenius Kabi. The logo consists of a blue abstract symbol on the left and the words "FRESENIUS KABI" in blue on the right. The abstract symbol appears to be three vertical wavy lines. The words "FRESENIUS" and "KABI" are stacked on top of each other. Fresenius Kabi Thee Corporation Drive Lake Zurich, Illinois 60047 T 847-5550-2330 T 8847-5550-23300 T 888-3391-23300 www.fresenius-kabi.us ### Table 3: Administration/Transfusion Set Material Comparison Table | Component | Modified Volumat I.V. Administration Set (Subject Device) | Baxter Administration Set K203609 (Predicate Device) | Assessment of Differences | |----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------| | Spike | Polystyrene | Acrylonitrile Butadiene Styrene | Similar, testing to biocompatibility and performance standards demonstrated equivalence | | Component | Modified Volumat I.V. Administration Set (Subject Device) | Baxter Administration Set K203609 (Predicate Device) | Assessment of Differences | | Drip chamber | Polystyrene, styrene- butadiene-copolymer, Polyamide | Polyvinyl Chloride | Different, testing to biocompatibility and performance standards demonstrated equivalence | | Backcheck Valve | Methylmethacrylate- Acrylonitrile-Butadiene- Styrene) | Polymethyl methacrylate (acrylic) | Similar, testing to biocompatibility and performance standards demonstrated equivalence | | Pump Segment | Methylmethacrylate- Acrylonitrile-Butadiene- Styrene | N/A - predicate device does not have a pump segment Silicone Rubber | Testing to biocompatibility and performance standards demonstrated equivalence | | Downstream Filter | Polyacryl, polyethersulfone | N/A - predicate device does not have a downstream filter | Testing to biocompatibility and performance standards demonstrated equivalence | | Needle Free Port | Methylmethacrylate- Acrylonitrile-Butadiene- Styrene, Copolyester | Polyester | Similar, Testing to biocompatibility and performance standards demonstrated equivalence | | Rotating Male Luer Lock | Polyvinylchloride, Acrylonitrile butadiene styrene | Acrylonitrile butadiene styrene | Similar, Testing to biocompatibility and performance standards demonstrated equivalence | | Y-Connector | Methylmethacrylate- Acrylonitrile-Butadiene- Styrene | Polyvinyl chloride | Different, testing to biocompatibility and performance standards demonstrated equivalence | | Tubing | Polyvinyl chloride, Polyurethane, Polypropylene | Polyvinyl chloride | Similar, Testing to biocompatibility and performance standards demonstrated equivalence | | Burette | Acrylonitrile-Butadiene- Styrene, Polyvinylchloride, Copolyester, Polyethylene, Versapor, Stainless steel, Polyamid, Polycarbonate | N/A - predicate device does not have a burette | Different, testing to biocompatibility and performance standards demonstrated equivalence | {11}------------------------------------------------ Image /page/11/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of three blue, curved lines on the left side. To the right of the lines, the words "FRESENIUS" and "KABI" are written in blue, with "FRESENIUS" on top of "KABI." Fresenius Kabi Three Corporate Drive Lake Zurich, Illinois 60047 T 847-550-2300 T 847-550-2300 T 888-391-6300 www.fresenius-kabi.us ## 9. Substantial Equivalence Discussion Intended Use/Indication for Use-Discussion of Differences {12}------------------------------------------------ Image /page/12/Picture/0 description: The image contains the logo for Fresenius Kabi. The logo consists of three blue, wavy lines on the left side. To the right of the lines, the words "FRESENIUS" and "KABI" are written in blue, with "FRESENIUS" on top of "KABI". The logo is simple and modern, with a focus on the company name. vw.fresenius-kabi.us Both the subject and predicate device have the same intended use and similar indication for use. Both I.V. administration sets are used to administer fluids with infusion pumps as well as for gravity flow. ### Technological Characteristics-Discussion of Differences Note: All performance testing / design control activities has been conducted and has confirmed that the different technological characteristics of the proposed devices do not raise different questions of safety and effectiveness. See performance testing below for standards/methods used to evaluate these technological characteristic differences. - Both the subject and predicate device can be used with an infusion pump or by gravity flow. The subject device delivers the intravenous infusions via an infusion pump through a pumping mechanism ("cassette") or by gravity flow, and the predicate device does not have a pumping mechanism ("cassette"). However, both devices have a pump set interface that was verified through flow rate testing. - The subject device ranges in length from 75 inches to 115 inches, which is within the length range of the predicate device. Difference tested according to ISO 8536-4 and flow rate accuracy to demonstrate the subject device performance. - . The subject device carries more priming volume than the predicate. Bench testing confirmed that the differences in priming volume do not impact safety or effectiveness. Difference tested to ISO 8536-4 to demonstrate equivalence. - . The subject device includes an additional downstream filter and burette. However, no significant difference between the subject and predicate administration sets that would raise new questions of safety and efficacy. The differences have been verified in various aspects to demonstrate the subject device's safety and performance including Biocompatibility testing according to ISO 10993 collateral standards, Microbial Ingress Testing, and Particulate Testing: Performance Testing according to ISO 8536-4, ISO 80369-20, ISO 8536-8. #### Conclusion on Substantial Equivalence The subject device has the same intended use and equivalent indications fruse as the predicate device. It also has similar technological characteristics to the predicate, and the descriptive as well as the performance information provided within this premarket notification demonstrates that: - . any differences do not raise different questions of safety and effectiveness compared to the predicate device; and {13}------------------------------------------------ Image /page/13/Picture/0 description: The image contains the logo for Fresenius Kabi. On the left side of the logo are three blue wavy lines stacked vertically. To the right of the wavy lines is the text "FRESENIUS" stacked on top of the text "KABI". The text is also in blue. ee Cornorate Drive Zurich, Illinois 60047 888-391-6300 www.fresenius-kabi.us - the proposed device is at least as safe and effective as the legally marketed predicate device. Based on the comparison of the intended use and the technological characteristics, the subject device is substantially equivalent to the predicate device. ## 10.Performance Testing ### Performance Testing-Bench Functional performance bench testing was conducted to demonstrate that the Volumat I.V. Administration Set performs as intended. The following performance testing was conducted to support the substantial equivalence determination: - ISO 8536-8 . - o Leakage Testing - Tensile Strength Testing o - o Storage Tube Volume Testing - ISO 80369-20 ● - o Luer Fittings Leakage Testing - Stress Cracking o - Resistance to Separation from Axial Loading O - Resistance to Separation from Unscrewing о - Resistance to Overriding o - ISO 8536-4 ● - Closure-piercing Device Testing o - Air-inlet Device Testing O - Tubing Testing O - Fluid Filter Testing O - O Flow Rate Testing of the Infusion Pump - Drip Chamber Testing O - O Clamp Opening and Closing - Protective Cap Testing o - o Chemical Compatibility Testing - ISO 8536-14 - 0 Clamps and flow regulators Testing - ISO 11607-1 and ASTM D4169 ● - o Sterile barrier and packaging systems and simulated shipping {14}------------------------------------------------ Image /page/14/Picture/0 description: The image shows the logo for Fresenius Kabi. The logo consists of three blue, curved lines on the left side. To the right of the lines, the words "FRESENIUS" and "KABI" are written in blue, with "FRESENIUS" on top of "KABI". w.fresenius-kabi.us - USP<788> Particulate Matter in Injections ● - o Particulate Testing - Pump Segment Compatibility Testing with Infusion Pump - Operation under Temperature, Pressure and Humidity ● - Microbial Ingress Testing ● # 11.Biocompatibility Testing Following the FDA Guidance: "Use of International Standard ISO 10993-1, Biological evaluation of medical devices-Part 1: Evaluation and testing within a risk management process", the tests selected were for prolonged, blood path indirect, externally communicating devices. The following biocompatibility tests were successfully conducted on the Volumat I.V. Administration Set: - Acute Systemic Toxicity ● - Hemolysis ● - Intracutaneous Reactivity ● - Sensitization ● - Cytotoxicity ● - Pyrogens ● - Subacute/subchronic toxicity ● - Targeted Chemical Analysis for DEHP # 12. Sterilization Validation Sterilization was achieved by ethylene oxide and meets the requirements of ISO 11135:2020, which is equivalent to ISO 11135 (2014-7) + AMD 1 (2018-10). The ethylene oxide sterilization method achieves a Sterilization Assurance Level (SAL) of 10-6. # 13. Clinical Testing No clinical testing was performed as this device does not require clinical studies to demonstrate substantial equivalence with the predicate device. # 14. Conclusion The differences between the predicate and the subject device do not raise any new or different questions of safety or effectiveness. The subject device, Volumat™ {15}------------------------------------------------ Image /page/15/Picture/0 description: The image contains the logo for Fresenius Kabi. On the left side of the logo are three blue vertical wavy lines. To the right of the wavy lines is the text "FRESENIUS KABI" in blue font. The word "FRESENIUS" is on the top line and the word "KABI" is on the bottom line. Fresenius Kabi Thee Corporation Drive Lake Zurich, Illinois 60047 T 847-5550-2330 T 8847-5550-23300 T 888-3391-23300 www.fresenius-kabi.us Line is substantially equivalent to the predicate device, I.V. Administration Set, cleared under K203609.

Volumat Line

Device Facts

Intended Use

Device Story

Clinical Evidence

Technological Characteristics

Indications for Use

Regulatory Classification

Identification

Special Controls

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

Panel 1

Section Matches

Product Code Matches

Special Control Matches

My Alerts

Volumat Line

Device Facts

Intended Use

Device Story

Clinical Evidence

Technological Characteristics

Indications for Use

Regulatory Classification

Identification

Special Controls

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

Panel 1

Section Matches

Product Code Matches

Special Control Matches

My Alerts

Create Alert

Search Filters

Welcome

Check your email

Welcome!